TYK350: Difference between revisions
https://pedsanesthesia.net/wikiOLD032021>TYK bot Bot: Automated import of articles |
m Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK" |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 28: | Line 28: | ||
<p style="text-align: center;">[[TYK349|<Prev Question]] --- [[TYK351|Next Question>]]</p> | <p style="text-align: center;">[[TYK349|<Prev Question]] --- [[TYK351|Next Question>]]</p> | ||
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | <p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p> | ||
[[Category:TYK]] | |||
[[Category:TYK]] | |||
Latest revision as of 02:44, 25 September 2026
Current evidence suggests that anemia associated with sickle cell disease:
a) Is of clinical significance only when associated with evidence of acute chest syndrome.
b) Should be corrected preoperatively by aggressive transfusion to decrease the hemoglobin S concentration to less than 30%.
c) Should be corrected preoperatively to increase the hemoglobin to 10 g/dL.
d) Should not be corrected preoperatively given the risk of alloimmunization.
Click for Answer
Answer
Answer c. Evidence suggests a lower incidence of complications with similar clinical outcomes with simple transfusion to correct anemia associated with sickle cell disease to a hemoglobin concentration of 10 g/dL.
Notes
- This question originally printed in the Pediatric Anesthesiology Review Topics kindle book series, and appears courtesy of Naerthwyn Press, LLC.